DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Antagonistic Interaction CB1-paracetamol

Information source: University Hospital, Clermont-Ferrand
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Pain

Intervention: Rimonabant and Paracetamol and placebo (Drug)

Phase: Phase 1

Status: Recruiting

Sponsored by: University Hospital, Clermont-Ferrand

Official(s) and/or principal investigator(s):
Dubray Claude, Pr, Principal Investigator, Affiliation: University Hospital, Clermont-Ferrand

Overall contact:
DUBRAY Claude, Pr, Phone: 04.73.17.84.10, Email: cdubray@chu-clermontferrand.fr

Summary

Evaluation of an possible inhibiting effect of Rimonabant on the analgesic effect of Paracetamol in healthy volunteers

Clinical Details

Official title: Evaluation of the Interaction of Rimonabant (Antagonist of CB1 Receptor) on the Analgesic Effect of Paracetamol in Intravenous Administration

Study design: Treatment, Randomized, Double Blind (Subject, Investigator), Placebo Control, Crossover Assignment, Pharmacodynamics Study

Primary outcome: Pain's threshold with electrical stimulation (Pain Matcher). Pain's threshold with mechanical stimulation (electronical Von Frey).

Secondary outcome: Plasmatic concentration of paracetamol or his metabolite with or without Rimonabant

Detailed description: Double Blind, cross-over, randomized and controlled versus placebo, study in healthy volunteers.

Eligibility

Minimum age: 18 Years. Maximum age: 40 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Healthy volunteers

- between 18 and 40 years old

- written consent given

Exclusion Criteria:

- Rimonabant or paracetamol hypersensibility

- Excessive consumption of alcohol, tobacco, coffee, tea or toxicomania

- Concomitant medication

- Chronical diseases

Locations and Contacts

DUBRAY Claude, Pr, Phone: 04.73.17.84.10, Email: cdubray@chu-clermontferrand.fr

CIC-CPC, Clermont-Ferrand 63000, France; Not yet recruiting
Dubray Claude, Pr, Phone: 04.73.17.84.10, Email: cdubray@chu-clermontferrand.fr

CHU Clermont-Ferrand, Clermont-Ferrand 63003, France; Recruiting
Patrick Lacarin, Email: placarin@chu-clermontferrand.fr

Additional Information

Starting date: September 2008
Ending date: November 2009
Last updated: October 1, 2009

Page last updated: October 19, 2009

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009